Role of inactivated SARS-CoV-2 vaccine induced T cell responses in ameliorating COVID-19 severity.

Huang, Hongming; Liu, Jia

Huang, Hongming; Liu, Jia.

Huang H; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Liu J; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China; Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, 430022, China. Electronic address: jialiu77@hust.edu.cn.

Virol Sin ; 38(2): 324-326, 2023 04.

Article in English | MEDLINE | ID: covidwho-2263433

Subject(s)

COVID-19 Vaccines; COVID-19; Humans; SARS-CoV-2; T-Lymphocytes; Vaccines, Inactivated; Antibodies, Viral

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Type of study: Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Virol Sin Journal subject: Virology Year: 2023 Document Type: Article Affiliation country: J.virs.2023.02.003

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google